ARTICLE | Company News
Cephalon, Champions Biotechnology deal
September 20, 2010 7:00 AM UTC
Champions will use its Biomerk Tumorgraft technology to test the efficacy of Cephalon's BRAF inhibitor CEP-32496 for cancer. The technology uses implantation of human tumors in immune deficient mice...